Cross-talk of the related bioactivity mediators in serum after injection of soluble TNF-α receptor on silicosis model of rats

Toxicology and Industrial Health

Volumn 27, Issue 7, 2011, Pages 607-616

  Gao, Hong Sheng ^a   Rong Xue, ^a   Peng Ding, ^a   Chen, Nan Fang ^a   Bing Meng, ^a   Zhao, Hua Bing ^a   Zhen Yang, ^a   Wang, Shi Xing ^a  

^a Medical College of China People's Armed Police Force   (China)

Author keywords

bioactivity mediator; IFN ; NF B; Silicosis; soluble TNF receptor; TGF

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; NITRIC OXIDE; SILICON DIOXIDE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; GENE EXPRESSION; MALE; NONHUMAN; RAT; SIGNAL TRANSDUCTION; SILICOSIS; STATISTICAL SIGNIFICANCE; UPREGULATION;

ANIMALS; COLLAGEN; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-1BETA; MALE; NF-KAPPA B; NITRIC OXIDE; RATS; RATS, WISTAR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; SILICON DIOXIDE; SILICOSIS; TRANSFORMING GROWTH FACTOR BETA1;

RATTUS; RATTUS NORVEGICUS;

EID: 79960967247     PISSN: 07482337     EISSN: None     Source Type: Journal    
DOI: 10.1177/0748233710393778     Document Type: Article

References (21)

1. Berclaz PY, Carey B., Fillipi MD, Wernke-Dollries K., Geraci N., Cush S., et al. (2007) GM-CSF Regulates a PU.1-Dependent Transcriptional Program Determining the Pulmonary Response to LPS. American Journal of Respiratory Cell and Molecular Biology, 36(1): 114-121.
2. Broide DH, Stachnick G., Castaneda D., Nayar J., and Sriramarao P. (2001) Inhibition of eosinophilic inflammation in allergen-challenged TNF receptor p55/p75-and TNF receptor p55-deficient mice. American Journal of Respiratory Cell and Molecular Biology, 24: 304-311.
3. Cheong R., Hoffmann A., and Levchenko A. (2008) Understanding NF-κB signaling via mathematical modeling. Molecular and System Biology, 4: 192.
4. Crisby M., Nordin-Fredriksson G., Shah PK, Yano J., Zhu J., and Nilsson J. (2001) Pravastatin treatment increases collagen content and dreasea lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques. Circulation, 103: 926-933.
5. Di Giuseppe M., Gambelli F., Hoyle GW, Lungarella G., Studer SM, Richards T., et al. (2009) Systemic Inhibition of NF-κB Activation Protects from Silicosis. PLoS ONE, 4(5): e5689.
6. Gabbiani G. (2003) The myofibroblast in wound healing and fibrocontractive diseases. Journal of Pathology, 200: 500-503.
7. Giannopoulou M., Iszkula SC, Dai C., Tan X., Yang J., Michalopoulos GK, et al. (2006) Distinctive role of Stat3 and Erk-1/2 activation in mediating interferon-γ inhibition of TGF-β1 action. American Journal of Physiology and Renal Physiology, 290(5): 1234-40.
8. Greten FR and Karin M. (2004) The IKK/NF-κB activation pathway-A target for prevention and treatment of cancer. Cancer Letter, 206:193-199.
9. Hubbard AK, Timblin CR, Shukla A., Rincón M., and Mossman BT (2002) Activation of NF-κB dependent gene expression by silica in lungs of luciferase reporter mice. American Journal of Physiology and Lung Cell Molecular Physiolology, 282:968-975.
10. Jiang D., Liang J., Hodge J., Lu B., Zhu Z., Yu S., et al.(2004) Regulation of pulmonary fibrosis by chemokine receptor CXCR3. Journal of Clinical Investment, 114(2): 291-299.
11. Kolb M., Margetts PJ, Anthony DC, Pitossi F., and Gauldie J. (2001) Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis. Journal of Clinical Investment, 107(12): 1529-1536.
12. Moore BB, Coffey MJ, Christensen P., Sitterding S., Ngan R., Wilke CA, et al. (2000) GM-CSF Regulates bleomycin-induced pulmonary fibrosis via a prostaglandin-dependent mechanism. Journal of Immunology, 165(7): 4032-4039.
13. Nam HS, Lee SY, Kim SJ, Kim JS, Kwon SS, Kim YK, et al. (2009) The Soluble Tumor Necrosis Factor-Alpha Receptor Suppresses Airway Inflammation in a Murine Model of Acute Asthma. Yonsei Medecine of Journal, 50(4): 569-575.
14. Paul J., Marc B., Bailie, Richard, E. Goodman, Aidan D., O’Brien, Galen, B. Toews, and Robert Paine III (2000) Role of diminished epithelial GM-CSF in thepathogenesis of bleomycin-induced pulmonary fibrosis. American Journal of Physiology and Lung Cell Molecular Physiology, 279: 487-495.
15. Robertson M., Liversidge J., Forrester JV, and Dick AD (2003) Neutralizing tumor necrosis factor activity suppresses activation of infiltrating macrophages in experimental autoimmune uveoretinitis. Investigative Ophthalmology & Visual Science. 2003; 44(7):3034-3041.
16. Sakurai H., Miyoshi H., Toriumi W., and Sugita T. (1999) Functional interactions of TGF-β-activated kinase 1 with IκB kinases to stimulate NF-κB activation. Journal of Biological Chemistry, 274: 10641-10648.
17. Sakurai H., Nishi A., Sato N., Mizukami J., Miyoshi H., and Sugita T. (2002) TAK1-TAB1 fusion protein: a novel constitutively active mitogen-activated protein kinase kinase kinase that stimulates AP-1 and NF-κB signaling pathways. Biochemical and Biophysical Research Communications, 297(5):1277-1281.
18. Srirupa Mukhopadhyay, John R Hoidal, and Tapan K Mukherjee (2006) Role of TNF-α in pulmonary pathophysiology. Respiratory Research, 7(1): 125.
19. Takaesu G., Surabhi RM, Park KJ, Ninomiya-Tsuji J., Matsumoto K., and Gaynor RB (2003) TAK1 is critical for IκB kinase-mediated activation of the NF-κB pathway. Journal of Molecular Biology, 326(1): 105-115.
20. Ye Q., Chen B., Tong Z., Nakamura S., Sarria R., Costabel U., et al. (2006) Thalidomide reduces IL-18, IL-8 and TNF-alpha release from alveolar macrophages in interstitial lung disease. European Respiratory Journal, 28(4): 824-831.
21. Xing Z., Gauldie J., Tremblay GM, Hewlett BR, and Addison C. (1997) Intradermal transgenic expression of granulocyte-macrophage colony-stimulating factor induces neutrophilia, epidermal hyperplasia, Langerhans’ cell/macrophage accumulation, and dermal fibrosis. Laboratory Investigation, 77(6): 615-622.